Literature DB >> 1663716

Cytochrome oxidase deficiency in Alzheimer's disease.

W D Parker1.   

Abstract

Alzheimer's disease (AD) is a degenerative neurologic disorder that may be familial but is usually sporadic and not easily analyzable in terms of conventional Mendelian genetics. The mitochondrial electron transport chain contains 13 proteins that are encoded by mitochondrial genes rather than nuclear (chromosomal) genes. Disorders resulting from heteroplasmic mutations of mitochondrial genes may appear to be sporadic rather than familial. We evaluated electron transport chain activity in platelet mitochondria prepared from patients with AD and found a specific defect in cytochrome oxidase in five of six patients studied. The mitochondrial genome may play a role in the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663716     DOI: 10.1111/j.1749-6632.1991.tb00191.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  29 in total

1.  Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction.

Authors:  Latha Devi; Badanavalu M Prabhu; Domenico F Galati; Narayan G Avadhani; Hindupur K Anandatheerthavarada
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

Review 2.  Mitochondria, calcium and cell death: a deadly triad in neurodegeneration.

Authors:  Fulvio Celsi; Paola Pizzo; Marisa Brini; Sara Leo; Carmen Fotino; Paolo Pinton; Rosario Rizzuto
Journal:  Biochim Biophys Acta       Date:  2009-03-04

Review 3.  Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.

Authors:  Peter J Adhihetty; M Flint Beal
Journal:  Neuromolecular Med       Date:  2008-11-13       Impact factor: 3.843

4.  Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease.

Authors:  J P Sheehan; R H Swerdlow; S W Miller; R E Davis; J K Parks; W D Parker; J B Tuttle
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

Review 5.  Is ammonia a pathogenetic factor in Alzheimer's disease?

Authors:  N Seiler
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

Review 6.  Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities.

Authors:  Charles C Caldwell; Jia Yao; Roberta Diaz Brinton
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 7.  Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

Authors:  Jia Yao; Roberta Diaz Brinton
Journal:  Adv Pharmacol       Date:  2012

Review 8.  Mitochondrial quality control and neurological disease: an emerging connection.

Authors:  Inês Pimenta de Castro; L Miguel Martins; Roberta Tufi
Journal:  Expert Rev Mol Med       Date:  2010-04-19       Impact factor: 5.600

Review 9.  Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.

Authors:  Latha Devi; Hindupur K Anandatheerthavarada
Journal:  Biochim Biophys Acta       Date:  2009-07-18

10.  Transcranial Laser Stimulation as Neuroenhancement for Attention Bias Modification in Adults with Elevated Depression Symptoms.

Authors:  Seth G Disner; Christopher G Beevers; Francisco Gonzalez-Lima
Journal:  Brain Stimul       Date:  2016-05-24       Impact factor: 8.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.